To Intensify or Not to Intensify? Consideration of Competing Risks in the Management of Locoregionally Advanced p16+ Oropharyngeal Cancer
- PMID: 32589985
- DOI: 10.1016/j.ijrobp.2018.09.034
To Intensify or Not to Intensify? Consideration of Competing Risks in the Management of Locoregionally Advanced p16+ Oropharyngeal Cancer
Comment in
-
High Dose Cisplatin: Still the One?Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):615-616. doi: 10.1016/j.ijrobp.2019.09.026. Int J Radiat Oncol Biol Phys. 2020. PMID: 32589986 No abstract available.
-
Regular Ol' Intensity.Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):615. doi: 10.1016/j.ijrobp.2018.10.028. Int J Radiat Oncol Biol Phys. 2020. PMID: 32589987 No abstract available.
-
To Shy Away From Chemotherapy Is to Compromise.Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):616-617. doi: 10.1016/j.ijrobp.2020.05.024. Int J Radiat Oncol Biol Phys. 2020. PMID: 32589988 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
